EN
登录

Gravity Diagnostics扩大检测服务,包括木霉嗪检测:确保公共安全的关键进展

Gravity Diagnostics Expands Testing Services to Include Xylazine Detection: A Crucial Advancement in Ensuring Public Safety

globenewswire 等信源发布 2023-09-21 04:53

可切换为仅中文


Covington, KY, Sept. 20, 2023 (GLOBE NEWSWIRE) -- **FOR IMMEDIATE RELEASE** [[Covington, KY] – [9/20/23] – Gravity Diagnostics, a leading clinical toxicology laboratory, is announcing a significant expansion of their testing services. They are now offering comprehensive testing for Xylazine, a powerful sedative and muscle relaxant.

2023年9月20日,肯塔基州科文顿市(GLOBE NEWSWIRE)-**即时发布**[[Covington,KY]-[9/20/23]-重力诊断公司是一家领先的临床毒理学实验室,宣布大幅扩展他们的测试服务。他们现在正在提供甲苯噻嗪的全面测试,甲苯噻嗪是一种强效镇静剂和肌肉松弛剂。

This groundbreaking addition to their testing portfolio demonstrates their unwavering commitment to advancing public health and safety. Xylazine, originally developed as a veterinary drug, has increasingly found its way into illicit drug markets. As a potent central nervous system depressant, it poses serious risks to both users and the communities in which it is circulating.

他们的测试产品组合的这一开创性补充表明他们对推进公共健康和安全的坚定承诺。最初作为兽药开发的赛拉嗪越来越多地进入非法药物市场。作为一种有效的中枢神经系统抑制剂,它对用户及其传播的社区都构成严重风险。

According to the CDC, the number of deaths from illicitly manufactured fentanyl containing Xylazine rose by 276% from January 2019 to June 2022. By including Xylazine in their testing menu, Gravity Diagnostics aims to address the growing concerns surrounding its use and provide critical information to healthcare providers.

据CDC称,从2019年1月至2022年6月,非法制造的含芬太尼的甲苯噻嗪死亡人数上升了276%。通过在其测试菜单中包含甲苯噻嗪,重力诊断旨在解决围绕其使用的日益增长的担忧,并向医疗保健提供者提供关键信息。

**Why Testing for Xylazine is Essential: ** **Enhancing Patient Safety**: Xylazine is frequently employed as an adulterant in street drugs, particularly in opioids such as fentanyl and heroin. Its inclusion in illicit substances significantly heightens the danger of overdose and adverse health consequences.

**为什么测试甲苯噻嗪是必不可少的:****增强患者安全**:甲苯噻嗪经常被用作街头毒品中的掺杂物,特别是在芬太尼和海洛因等阿片类药物中。将其纳入非法物质会显着增加过量和不良健康后果的危险。

The identification of Xylazine in drug samples empowers healthcare providers to make well-informed choices regarding patient care and the selection of treatment strategies. **Advancing Harm Reduction**: Awareness of the presence of Xylazine in illicit drugs can equip harm reduction organizations, substance use disorder treatment providers and community outreach programs to educate at-risk populations more effectively about the potential hazards an.

药物样品中甲苯噻嗪的鉴定使医疗保健提供者能够就患者护理和治疗策略的选择做出明智的选择**推进减少危害**:意识到非法药物中存在甲苯噻嗪可以帮助减少危害的组织,物质使用障碍治疗提供者和社区外展计划更有效地教育高危人群an的潜在危害。

Attachment

附件

Gravity Diagnostics Expands Testing Services to Include Xylazine Detection

重力诊断扩展了测试服务,包括Xylazine检测